�ݺ�ߣshows by User: annasxhan

�ݺ�ߣshows by User: annasxhan / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: annasxhan / Fri, 17 Jun 2022 15:26:22 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: annasxhan Anti DM drug and HF .pptx /slideshow/anti-dm-drug-and-hf-pptx/252007964 antidmdrugandhf-220617152622-2dce92f6
Impact of Newer Glucose-Lowering Agents in CVD & HF , and Novel Therapeutic Strategies Han Naung Tun MBBS, MD, FACTM, FACC, FESC UVM Medical Centre Larner College of Medicine , University of Vermont ,VT , USA ]]>
Impact of Newer Glucose-Lowering Agents in CVD & HF , and Novel Therapeutic Strategies Han Naung Tun MBBS, MD, FACTM, FACC, FESC UVM Medical Centre Larner College of Medicine , University of Vermont ,VT , USA ]]> Fri, 17 Jun 2022 15:26:22 GMT /slideshow/anti-dm-drug-and-hf-pptx/252007964 annasxhan@slideshare.net(annasxhan) Anti DM drug and HF .pptx annasxhan Impact of Newer Glucose-Lowering Agents in CVD & HF , and Novel Therapeutic Strategies Han Naung Tun MBBS, MD, FACTM, FACC, FESC UVM Medical Centre Larner College of Medicine , University of Vermont ,VT , USA <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/antidmdrugandhf-220617152622-2dce92f6-thumbnail.jpg?width=120&height=120&fit=bounds" /> Impact of Newer Glucose-Lowering Agents in CVD & HF , and Novel Therapeutic Strategies Han Naung Tun MBBS, MD, FACTM, FACC, FESC UVM Medical Centre Larner College of Medicine , University of Vermont ,VT , USA

Anti DM drug and HF .pptx from Han Naung Tun

]]> 99 0 https://cdn.slidesharecdn.com/ss_thumbnails/antidmdrugandhf-220617152622-2dce92f6-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon /slideshow/coronary-artery-disease-in-heart-failure-what-we-have-learned-and-the-horizon/251780065 cadinhf-220514013228-a7c979d8
Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon By Dr Han Naung Tun, MBBS, MD, FACC, FESC]]>
Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon By Dr Han Naung Tun, MBBS, MD, FACC, FESC]]> Sat, 14 May 2022 01:32:28 GMT /slideshow/coronary-artery-disease-in-heart-failure-what-we-have-learned-and-the-horizon/251780065 annasxhan@slideshare.net(annasxhan) Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon annasxhan Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon By Dr Han Naung Tun, MBBS, MD, FACC, FESC <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cadinhf-220514013228-a7c979d8-thumbnail.jpg?width=120&height=120&fit=bounds" /> Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon By Dr Han Naung Tun, MBBS, MD, FACC, FESC

Coronary Artery Disease in Heart Failure : What We Have Learned and the Horizon from Han Naung Tun

]]> 149 0 https://cdn.slidesharecdn.com/ss_thumbnails/cadinhf-220514013228-a7c979d8-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Usefulness of multimodality imaging for myocardial viability /slideshow/usefulness-of-multimodality-imaging-for-myocardial-viability/250074737 usefulnessofmultimodalityimagingformyocardialviability-210830003256
Usefulness of Multimodality Imaging for Myocardial Viability Tips & Tricks ,and an EACVI Expert Consensus Document By Han Naung Tun ]]>
Usefulness of Multimodality Imaging for Myocardial Viability Tips & Tricks ,and an EACVI Expert Consensus Document By Han Naung Tun ]]> Mon, 30 Aug 2021 00:32:55 GMT /slideshow/usefulness-of-multimodality-imaging-for-myocardial-viability/250074737 annasxhan@slideshare.net(annasxhan) Usefulness of multimodality imaging for myocardial viability annasxhan Usefulness of Multimodality Imaging for Myocardial Viability Tips & Tricks ,and an EACVI Expert Consensus Document By Han Naung Tun <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/usefulnessofmultimodalityimagingformyocardialviability-210830003256-thumbnail.jpg?width=120&height=120&fit=bounds" /> Usefulness of Multimodality Imaging for Myocardial Viability Tips & Tricks ,and an EACVI Expert Consensus Document By Han Naung Tun

Usefulness of multimodality imaging for myocardial viability from Han Naung Tun

]]> 239 0 https://cdn.slidesharecdn.com/ss_thumbnails/usefulnessofmultimodalityimagingformyocardialviability-210830003256-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Latest Trials on CAD from 2020 ESC Congress /slideshow/latest-trials-on-cad-from-2020-esc-congress/249900020 cad2020updatetrials-210801204157
LoDoCo2 Trial: low-dose colchicine reduced the risk of major cardiovascular events in patients with CAD ATPCI: Trimetazidine in Angina Patients With Recent Successful Percutaneous Coronary Intervention RAPID CTCA :Early Coronary CT Angiography in Patients With Suspected or Provisionally Diagnosed Acute Coronary Syndrome OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP ]]>
LoDoCo2 Trial: low-dose colchicine reduced the risk of major cardiovascular events in patients with CAD ATPCI: Trimetazidine in Angina Patients With Recent Successful Percutaneous Coronary Intervention RAPID CTCA :Early Coronary CT Angiography in Patients With Suspected or Provisionally Diagnosed Acute Coronary Syndrome OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP ]]> Sun, 01 Aug 2021 20:41:56 GMT /slideshow/latest-trials-on-cad-from-2020-esc-congress/249900020 annasxhan@slideshare.net(annasxhan) Latest Trials on CAD from 2020 ESC Congress annasxhan LoDoCo2 Trial: low-dose colchicine reduced the risk of major cardiovascular events in patients with CAD ATPCI: Trimetazidine in Angina Patients With Recent Successful Percutaneous Coronary Intervention RAPID CTCA :Early Coronary CT Angiography in Patients With Suspected or Provisionally Diagnosed Acute Coronary Syndrome OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cad2020updatetrials-210801204157-thumbnail.jpg?width=120&height=120&fit=bounds" /> LoDoCo2 Trial: low-dose colchicine reduced the risk of major cardiovascular events in patients with CAD ATPCI: Trimetazidine in Angina Patients With Recent Successful Percutaneous Coronary Intervention RAPID CTCA :Early Coronary CT Angiography in Patients With Suspected or Provisionally Diagnosed Acute Coronary Syndrome OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

Latest Trials on CAD from 2020 ESC Congress from Han Naung Tun

]]> 197 0 https://cdn.slidesharecdn.com/ss_thumbnails/cad2020updatetrials-210801204157-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Ventricular septal rupture with cardiogenic shock follows by Inferior AMI /slideshow/ventricular-septal-rupture-with-cardiogenic-shock-follows-by-inferior-ami/239647056 ventricularseptalrupturewithcardiogenicshockfollowsby-201201085759
Main Topic: Acute Cardiac Care – Cardiogenic Shock with VSR ]]>
Main Topic: Acute Cardiac Care – Cardiogenic Shock with VSR ]]> Tue, 01 Dec 2020 08:57:59 GMT /slideshow/ventricular-septal-rupture-with-cardiogenic-shock-follows-by-inferior-ami/239647056 annasxhan@slideshare.net(annasxhan) Ventricular septal rupture with cardiogenic shock follows by Inferior AMI annasxhan Main Topic: Acute Cardiac Care – Cardiogenic Shock with VSR <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ventricularseptalrupturewithcardiogenicshockfollowsby-201201085759-thumbnail.jpg?width=120&height=120&fit=bounds" /> Main Topic: Acute Cardiac Care – Cardiogenic Shock with VSR

Ventricular septal rupture with cardiogenic shock follows by Inferior AMI from Han Naung Tun

]]> 236 0 https://cdn.slidesharecdn.com/ss_thumbnails/ventricularseptalrupturewithcardiogenicshockfollowsby-201201085759-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 HF Science News from AHA Scientific Sessions 2020 /slideshow/hf-science-news-from-aha-scientific-sessions-2020/239336454 hf-201119132647
HF Science News from AHA Scientific Sessions 2020 Dr Han Naung Tun (Henry Han) MBBS, MD, FACTM ]]>
HF Science News from AHA Scientific Sessions 2020 Dr Han Naung Tun (Henry Han) MBBS, MD, FACTM ]]> Thu, 19 Nov 2020 13:26:47 GMT /slideshow/hf-science-news-from-aha-scientific-sessions-2020/239336454 annasxhan@slideshare.net(annasxhan) HF Science News from AHA Scientific Sessions 2020 annasxhan HF Science News from AHA Scientific Sessions 2020 Dr Han Naung Tun (Henry Han) MBBS, MD, FACTM <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hf-201119132647-thumbnail.jpg?width=120&height=120&fit=bounds" /> HF Science News from AHA Scientific Sessions 2020 Dr Han Naung Tun (Henry Han) MBBS, MD, FACTM

HF Science News from AHA Scientific Sessions 2020 from Han Naung Tun

]]> 77 0 https://cdn.slidesharecdn.com/ss_thumbnails/hf-201119132647-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 ACE2 , Hypertension and SARS Cov2 /slideshow/ace2-hypertension-and-sars-cov2/238446073 ace2andhtn-200911012348
ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection by Daniel Batlle MD RAS Inhibitors in Hypertension and Heart Failure: TRUTHS AND MISTRUTHS OF TREATMENT IN THE COVID-19 ERA by J o r d y C o h e n , M D , M S C E From Hypertension 2020 , American Heart Association Copy RIght to Hypertension Session 2020 in American Heart Association ]]>
ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection by Daniel Batlle MD RAS Inhibitors in Hypertension and Heart Failure: TRUTHS AND MISTRUTHS OF TREATMENT IN THE COVID-19 ERA by J o r d y C o h e n , M D , M S C E From Hypertension 2020 , American Heart Association Copy RIght to Hypertension Session 2020 in American Heart Association ]]> Fri, 11 Sep 2020 01:23:48 GMT /slideshow/ace2-hypertension-and-sars-cov2/238446073 annasxhan@slideshare.net(annasxhan) ACE2 , Hypertension and SARS Cov2 annasxhan ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection by Daniel Batlle MD RAS Inhibitors in Hypertension and Heart Failure: TRUTHS AND MISTRUTHS OF TREATMENT IN THE COVID-19 ERA by J o r d y C o h e n , M D , M S C E From Hypertension 2020 , American Heart Association Copy RIght to Hypertension Session 2020 in American Heart Association <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ace2andhtn-200911012348-thumbnail.jpg?width=120&height=120&fit=bounds" /> ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection ACE2: From Renoprotection to a Potential Therapy for Coronavirus Infection by Daniel Batlle MD RAS Inhibitors in Hypertension and Heart Failure: TRUTHS AND MISTRUTHS OF TREATMENT IN THE COVID-19 ERA by J o r d y C o h e n , M D , M S C E From Hypertension 2020 , American Heart Association Copy RIght to Hypertension Session 2020 in American Heart Association

ACE2 , Hypertension and SARS Cov2 from Han Naung Tun

]]> 294 0 https://cdn.slidesharecdn.com/ss_thumbnails/ace2andhtn-200911012348-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Updated and Overview of HF Trials in ESC 2020 /slideshow/updated-and-overview-of-hf-trials-in-esc-2020/238375038 hf-200903020751
ESC Congress 2020, HF Trials Overview ]]>
ESC Congress 2020, HF Trials Overview ]]> Thu, 03 Sep 2020 02:07:50 GMT /slideshow/updated-and-overview-of-hf-trials-in-esc-2020/238375038 annasxhan@slideshare.net(annasxhan) Updated and Overview of HF Trials in ESC 2020 annasxhan ESC Congress 2020, HF Trials Overview <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hf-200903020751-thumbnail.jpg?width=120&height=120&fit=bounds" /> ESC Congress 2020, HF Trials Overview

Updated and Overview of HF Trials in ESC 2020 from Han Naung Tun

]]> 243 0 https://cdn.slidesharecdn.com/ss_thumbnails/hf-200903020751-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Hospital Readmission of Heart Failure Patients And Its Precipitated Factors and Hypertension /slideshow/hospital-readmission-of-heart-failure-patients-and-its-precipitated-factors-and-hypertension/237947038 ahahypertensionpresenatation-200816033050
Hypertension is one of the most prevalent modifiable risk factor for the development of heart failure (HF). Chronic heart failure (CHF) is the most common cause of readmission for patients in worldwide]]>
Hypertension is one of the most prevalent modifiable risk factor for the development of heart failure (HF). Chronic heart failure (CHF) is the most common cause of readmission for patients in worldwide]]> Sun, 16 Aug 2020 03:30:50 GMT /slideshow/hospital-readmission-of-heart-failure-patients-and-its-precipitated-factors-and-hypertension/237947038 annasxhan@slideshare.net(annasxhan) Hospital Readmission of Heart Failure Patients And Its Precipitated Factors and Hypertension annasxhan Hypertension is one of the most prevalent modifiable risk factor for the development of heart failure (HF). Chronic heart failure (CHF) is the most common cause of readmission for patients in worldwide <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ahahypertensionpresenatation-200816033050-thumbnail.jpg?width=120&height=120&fit=bounds" /> Hypertension is one of the most prevalent modifiable risk factor for the development of heart failure (HF). Chronic heart failure (CHF) is the most common cause of readmission for patients in worldwide

Hospital Readmission of Heart Failure Patients And Its Precipitated Factors and Hypertension from Han Naung Tun

]]> 163 0 https://cdn.slidesharecdn.com/ss_thumbnails/ahahypertensionpresenatation-200816033050-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Sudden cardiac death and cardiogenic shock a team approach to save heart and brain /slideshow/sudden-cardiac-death-and-cardiogenic-shock-a-team-approach-to-save-heart-and-brain/234820184 suddencardiacdeathandcardiogenicshockateamapproachtosaveheartandbrain-200601105425
Sudden cardiac death and cardiogenic shock a team approach to save heart and brain by Dr Han Naung Tun]]>
Sudden cardiac death and cardiogenic shock a team approach to save heart and brain by Dr Han Naung Tun]]> Mon, 01 Jun 2020 10:54:25 GMT /slideshow/sudden-cardiac-death-and-cardiogenic-shock-a-team-approach-to-save-heart-and-brain/234820184 annasxhan@slideshare.net(annasxhan) Sudden cardiac death and cardiogenic shock a team approach to save heart and brain annasxhan Sudden cardiac death and cardiogenic shock a team approach to save heart and brain by Dr Han Naung Tun <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/suddencardiacdeathandcardiogenicshockateamapproachtosaveheartandbrain-200601105425-thumbnail.jpg?width=120&height=120&fit=bounds" /> Sudden cardiac death and cardiogenic shock a team approach to save heart and brain by Dr Han Naung Tun

Sudden cardiac death and cardiogenic shock a team approach to save heart and brain from Han Naung Tun

]]> 183 0 https://cdn.slidesharecdn.com/ss_thumbnails/suddencardiacdeathandcardiogenicshockateamapproachtosaveheartandbrain-200601105425-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 How To Recognise and Manage a Pre Shock Setting /slideshow/how-to-recognise-and-manage-a-pre-shock-setting/234319312 howtorecogniseandmanageapre-shocksetting-200520050014
Shock, Anterior MI and Acute Cardiovascular Care ]]>
Shock, Anterior MI and Acute Cardiovascular Care ]]> Wed, 20 May 2020 05:00:14 GMT /slideshow/how-to-recognise-and-manage-a-pre-shock-setting/234319312 annasxhan@slideshare.net(annasxhan) How To Recognise and Manage a Pre Shock Setting annasxhan Shock, Anterior MI and Acute Cardiovascular Care <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/howtorecogniseandmanageapre-shocksetting-200520050014-thumbnail.jpg?width=120&height=120&fit=bounds" /> Shock, Anterior MI and Acute Cardiovascular Care

How To Recognise and Manage a Pre Shock Setting from Han Naung Tun

]]> 96 0 https://cdn.slidesharecdn.com/ss_thumbnails/howtorecogniseandmanageapre-shocksetting-200520050014-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Top Five Clinical Trials of PCI in 2019 /slideshow/top-five-clinical-trials-of-pci-in-2019/217587414 top5trialsofpciin2019-200109050705
"My five top trials in #interventionalcardiology in 2019". View this extensive slideset by Andreas Baumbach @EAPCIPresident where he covers the potential impact of these trials on clinical practice & their relevance for practice guidelines ow.ly/G64930q7R1K #ESC #EuroPCR]]>
"My five top trials in #interventionalcardiology in 2019". View this extensive slideset by Andreas Baumbach @EAPCIPresident where he covers the potential impact of these trials on clinical practice & their relevance for practice guidelines ow.ly/G64930q7R1K #ESC #EuroPCR]]> Thu, 09 Jan 2020 05:07:05 GMT /slideshow/top-five-clinical-trials-of-pci-in-2019/217587414 annasxhan@slideshare.net(annasxhan) Top Five Clinical Trials of PCI in 2019 annasxhan "My five top trials in #interventionalcardiology in 2019". View this extensive slideset by Andreas Baumbach @EAPCIPresident where he covers the potential impact of these trials on clinical practice & their relevance for practice guidelines ow.ly/G64930q7R1K #ESC #EuroPCR <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/top5trialsofpciin2019-200109050705-thumbnail.jpg?width=120&height=120&fit=bounds" /> "My five top trials in #interventionalcardiology in 2019". View this extensive slideset by Andreas Baumbach @EAPCIPresident where he covers the potential impact of these trials on clinical practice & their relevance for practice guidelines ow.ly/G64930q7R1K #ESC #EuroPCR

Top Five Clinical Trials of PCI in 2019 from Han Naung Tun

]]> 116 2 https://cdn.slidesharecdn.com/ss_thumbnails/top5trialsofpciin2019-200109050705-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CMR (basic and application) /slideshow/cmr-basic-and-application/188001255 cmrbasicandapplication-191029033152
Cardiac MRI , basic theory and its application by James C.Carr, MD]]>
Cardiac MRI , basic theory and its application by James C.Carr, MD]]> Tue, 29 Oct 2019 03:31:52 GMT /slideshow/cmr-basic-and-application/188001255 annasxhan@slideshare.net(annasxhan) CMR (basic and application) annasxhan Cardiac MRI , basic theory and its application by James C.Carr, MD <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cmrbasicandapplication-191029033152-thumbnail.jpg?width=120&height=120&fit=bounds" /> Cardiac MRI , basic theory and its application by James C.Carr, MD

CMR (basic and application) from Han Naung Tun

]]> 952 0 https://cdn.slidesharecdn.com/ss_thumbnails/cmrbasicandapplication-191029033152-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Cardio oncology /slideshow/cardio-oncology-167011255/167011255 cardio-oncology-190828035335
Cardio-oncology: Principles and organisational issues by Dr Han Naung Tun(Henry Han ) ]]>
Cardio-oncology: Principles and organisational issues by Dr Han Naung Tun(Henry Han ) ]]> Wed, 28 Aug 2019 03:53:35 GMT /slideshow/cardio-oncology-167011255/167011255 annasxhan@slideshare.net(annasxhan) Cardio oncology annasxhan Cardio-oncology: Principles and organisational issues by Dr Han Naung Tun(Henry Han ) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cardio-oncology-190828035335-thumbnail.jpg?width=120&height=120&fit=bounds" /> Cardio-oncology: Principles and organisational issues by Dr Han Naung Tun(Henry Han )

Cardio oncology from Han Naung Tun

]]> 1703 3 https://cdn.slidesharecdn.com/ss_thumbnails/cardio-oncology-190828035335-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Pre operative assessment of patient with liver disease /slideshow/pre-operative-assessment-of-patient-with-liver-disease/158345478 pre-operativeassessmentofpatientwithliverdisease25-190727154310
Dr Han Naung Tun MBBS, MD Cardiology ]]>
Dr Han Naung Tun MBBS, MD Cardiology ]]> Sat, 27 Jul 2019 15:43:10 GMT /slideshow/pre-operative-assessment-of-patient-with-liver-disease/158345478 annasxhan@slideshare.net(annasxhan) Pre operative assessment of patient with liver disease annasxhan Dr Han Naung Tun MBBS, MD Cardiology <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pre-operativeassessmentofpatientwithliverdisease25-190727154310-thumbnail.jpg?width=120&height=120&fit=bounds" /> Dr Han Naung Tun MBBS, MD Cardiology

Pre operative assessment of patient with liver disease from Han Naung Tun

]]> 806 3 https://cdn.slidesharecdn.com/ss_thumbnails/pre-operativeassessmentofpatientwithliverdisease25-190727154310-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Cardiac CT Angiography to detect Myocardial Bridging /slideshow/cardiac-ct-angiography-to-detect-myocardial-bridging/149038881 ctcamb-190607111154
CTCA : Non Invasive tool to detect myocardial bridging in CAD ]]>
CTCA : Non Invasive tool to detect myocardial bridging in CAD ]]> Fri, 07 Jun 2019 11:11:54 GMT /slideshow/cardiac-ct-angiography-to-detect-myocardial-bridging/149038881 annasxhan@slideshare.net(annasxhan) Cardiac CT Angiography to detect Myocardial Bridging annasxhan CTCA : Non Invasive tool to detect myocardial bridging in CAD <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ctcamb-190607111154-thumbnail.jpg?width=120&height=120&fit=bounds" /> CTCA : Non Invasive tool to detect myocardial bridging in CAD

Cardiac CT Angiography to detect Myocardial Bridging from Han Naung Tun

]]> 345 1 https://cdn.slidesharecdn.com/ss_thumbnails/ctcamb-190607111154-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Heart Failure Preserved EF /annasxhan/heart-failure-preserved-ef hfpefbydr-181220081722
Current and Future Therapeutic Perceptive]]>
Current and Future Therapeutic Perceptive]]> Thu, 20 Dec 2018 08:17:22 GMT /annasxhan/heart-failure-preserved-ef annasxhan@slideshare.net(annasxhan) Heart Failure Preserved EF annasxhan Current and Future Therapeutic Perceptive <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hfpefbydr-181220081722-thumbnail.jpg?width=120&height=120&fit=bounds" /> Current and Future Therapeutic Perceptive

Heart Failure Preserved EF from Han Naung Tun

]]> 2074 7 https://cdn.slidesharecdn.com/ss_thumbnails/hfpefbydr-181220081722-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Universal Definition of Myocardial Infarct /slideshow/universal-definition-of-myocardial-infarct/122388648 4thuniversalmi-181108075513
4th Universal MIUniversal Definition of Myocardial infarction, 2018]]>
4th Universal MIUniversal Definition of Myocardial infarction, 2018]]> Thu, 08 Nov 2018 07:55:12 GMT /slideshow/universal-definition-of-myocardial-infarct/122388648 annasxhan@slideshare.net(annasxhan) Universal Definition of Myocardial Infarct annasxhan 4th Universal MI�Universal Definition of Myocardial infarction, 2018 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/4thuniversalmi-181108075513-thumbnail.jpg?width=120&height=120&fit=bounds" /> 4th Universal MI�Universal Definition of Myocardial infarction, 2018

Universal Definition of Myocardial Infarct from Han Naung Tun

]]> 1691 5 https://cdn.slidesharecdn.com/ss_thumbnails/4thuniversalmi-181108075513-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Thrombolysis and thrombectomy for acute ischaemic stroke /slideshow/royal-college-of-physician-stork-guideline/119748890 storkguidelinercp-181017134648
Reperfusion by intravenous thrombolysis or endovascular mechanical thrombectomy improves functional outcomes after stroke, but benefit for both treatment modalities is highly time-dependent. Maximum benefit requires minimisation of onset-to-treatment times. The safety and efficacy of IV rtPA is established across a broad range of clinical scenarios. Endovascular treatment now offers greatly improved outcome among patients with poor response to IV rtPA but efficacy has been established only in the context of highly organised neurovascular interventional services.]]>
Reperfusion by intravenous thrombolysis or endovascular mechanical thrombectomy improves functional outcomes after stroke, but benefit for both treatment modalities is highly time-dependent. Maximum benefit requires minimisation of onset-to-treatment times. The safety and efficacy of IV rtPA is established across a broad range of clinical scenarios. Endovascular treatment now offers greatly improved outcome among patients with poor response to IV rtPA but efficacy has been established only in the context of highly organised neurovascular interventional services.]]> Wed, 17 Oct 2018 13:46:48 GMT /slideshow/royal-college-of-physician-stork-guideline/119748890 annasxhan@slideshare.net(annasxhan) Thrombolysis and thrombectomy for acute ischaemic stroke annasxhan Reperfusion by intravenous thrombolysis or endovascular mechanical thrombectomy improves functional outcomes after stroke, but benefit for both treatment modalities is highly time-dependent. Maximum benefit requires minimisation of onset-to-treatment times. The safety and efficacy of IV rtPA is established across a broad range of clinical scenarios. Endovascular treatment now offers greatly improved outcome among patients with poor response to IV rtPA but efficacy has been established only in the context of highly organised neurovascular interventional services. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/storkguidelinercp-181017134648-thumbnail.jpg?width=120&height=120&fit=bounds" /> Reperfusion by intravenous thrombolysis or endovascular mechanical thrombectomy improves functional outcomes after stroke, but benefit for both treatment modalities is highly time-dependent. Maximum benefit requires minimisation of onset-to-treatment times. The safety and efficacy of IV rtPA is established across a broad range of clinical scenarios. Endovascular treatment now offers greatly improved outcome among patients with poor response to IV rtPA but efficacy has been established only in the context of highly organised neurovascular interventional services.

Thrombolysis and thrombectomy for acute ischaemic stroke from Han Naung Tun

]]> 213 4 https://cdn.slidesharecdn.com/ss_thumbnails/storkguidelinercp-181017134648-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 40 years anniversary of PCI /slideshow/40-years-anniversary-of-pci/117937788 40yearsanniversaryofpci-181003081557
On the honour of Andreas Grunzig]]>
On the honour of Andreas Grunzig]]> Wed, 03 Oct 2018 08:15:57 GMT /slideshow/40-years-anniversary-of-pci/117937788 annasxhan@slideshare.net(annasxhan) 40 years anniversary of PCI annasxhan On the honour of Andreas Grunzig <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/40yearsanniversaryofpci-181003081557-thumbnail.jpg?width=120&height=120&fit=bounds" /> On the honour of Andreas Grunzig

40 years anniversary of PCI from Han Naung Tun

]]> 274 1 https://cdn.slidesharecdn.com/ss_thumbnails/40yearsanniversaryofpci-181003081557-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-annasxhan-48x48.jpg?cb=1713147666 Han Naung Tun, MBBS, MD, MPH, FACTM, FACC, FESC A Physician-scientist and Cardiologist ,Representative of Heart Failure Specialist of Tomorrow Heart Failure Association, ESC & Ambassador of Echocardigraphy for Myanmar in EACVI , ESC Specialities -Cardiology -Internal Medicine -Emergency Medicine -Infectious Medicine -Research and Clinical Trial hannaung.wordpress.com https://cdn.slidesharecdn.com/ss_thumbnails/antidmdrugandhf-220617152622-2dce92f6-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/anti-dm-drug-and-hf-pptx/252007964 Anti DM drug and HF .pptx https://cdn.slidesharecdn.com/ss_thumbnails/cadinhf-220514013228-a7c979d8-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/coronary-artery-disease-in-heart-failure-what-we-have-learned-and-the-horizon/251780065 Coronary Artery Diseas... https://cdn.slidesharecdn.com/ss_thumbnails/usefulnessofmultimodalityimagingformyocardialviability-210830003256-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/usefulness-of-multimodality-imaging-for-myocardial-viability/250074737 Usefulness of multimod...